Eyecelerator Innovation Award

"This year’s Eyecelerator Innovation Award honors Glaukos Corporation for its successful development and commercialization of first-of-kind innovations in Glaucoma and Cornea. The award celebrates the pioneering work of CEO Tom Burns and his visionary management team. 

 

They have brought forward groundbreaking innovative products through difficult FDA approvals to robust global commercialization, raising the standard of care in ophthalmology around the world. 

 

Glaukos is broadly admired around the world not only for its unique products, which garner clinical and financial success, but also for its very positive and high-integrity culture, which attracts and retains superlative employees.   

 

Eyecelerator salutes Glaukos as a meritorious example of a startup becoming a successful company by developing and delivering a portfolio of novel therapeutics for the global benefit of patients."